Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRUG pilot study of perioperative bridging from acenocoumarol to heparin
NL-OMON37436Recruiting
- Sponsor
- Philips
- Start
- Jun 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of acenocoumarol, heparin and low molecular weight heparin calcium in thromboembolism, sponsored by Philips. Primary endpoints: Validation of coagulation and PK/PD computer model in clinical practice and Therapeutic coagulation control during bridging. Started Jun 2013; status: recruiting.
02
Drugs
acenocoumarolheparinlow molecular weight heparin calcium
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NL-OMON37436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37436.